Hide metadata

dc.date.accessioned2021-01-26T19:17:28Z
dc.date.available2021-01-26T19:17:28Z
dc.date.created2021-01-18T16:19:08Z
dc.date.issued2020
dc.identifier.citationCorthay, Alexandre . The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases. Scandinavian Journal of Immunology. 2020, 92(2)
dc.identifier.urihttp://hdl.handle.net/10852/82642
dc.description.abstractPulmonary typical carcinoid (TC) is a low‐grade, rare lung cancer of neuroendocrine origin. Currently, there is very little information available about the immune cell composition in TC tumours. Here, we analysed by flow cytometry resected tumours from four never‐smoker female patients with TC. Twelve distinct immune cell types were identified in TC tumours. The most abundant immune cells were CD8+ T cells, CD4+ T cells, B cells and macrophages, which represented 19.8%, 17.7%, 11.5% and 11% of all tumour‐infiltrating CD45+ leucocytes, respectively. Natural killer (NK) cells (8.8%) and neutrophils (3.9%) were also common. Three types of dendritic cells (DCs) were identified (plasmacytoid DCs, CD1c DCs, and CD141 DCs) which together constituted 1.4% of all immune cells in TC tumours. Small populations of basophils (1.2%), mast cells (0.8%) and eosinophils (0.6%) were also present. Notably, the percentage of leucocytes (of all living cells) was much lower in TC tumours compared to high‐grade non‐small cell lung cancer (NSCLC) tumours and also compared to non‐cancerous lung tissue. We conclude that TC tumours are relatively non‐inflammatory, although the immune landscape was found to be very complex.
dc.languageEN
dc.publisherBlackwell Science Ltd.
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleThe immune microenvironment in typical carcinoid lung tumour, a brief report of four cases
dc.typeJournal article
dc.creator.authorCorthay, Alexandre
cristin.unitcode185,50,9,0
cristin.unitnameOUS IKT - tjenester for forskning
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1873524
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Scandinavian Journal of Immunology&rft.volume=92&rft.spage=&rft.date=2020
dc.identifier.jtitleScandinavian Journal of Immunology
dc.identifier.volume92
dc.identifier.issue2
dc.identifier.doihttps://doi.org/10.1111/sji.12893
dc.identifier.urnURN:NBN:no-85499
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0300-9475
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/82642/1/2020%2BStankovic%2BSJI.pdf
dc.type.versionPublishedVersion
cristin.articleide12893


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International